CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
OPERATING ACTIVITIES
Net income	$ 150,201	$ 58,417	$ (5,047)
Adjustments for non-cash items:
Depreciation	118,690	112,485	106,049
Amortization	12,988	14,003	13,811
Stock-based compensation expense	20,985	24,799	16,048
Restructuring and asset impairment charges	(753)	5,664	34,175
Deferred income tax provision	11,292	(21,189)	(23,899)
Gain (Loss) on divestiture	(1,001)		(6,517)
Debt Related Commitment Fees and Debt Issuance Costs		9,071
Other	(2,243)	6,754	2,613
Changes in certain assets and liabilities:
Accounts receivable	(14,432)	(53,324)	128,715
Inventories	(127,409)	61,270	28,185
Accounts payable and accrued liabilities	31,997	46,775	(46,315)
Accrued income taxes	10,238	(18,273)	(8,645)
Accrued pension and postretirement benefits	(24,216)	(31,585)	(20,022)
Other	(4,893)	20,815	(8,447)
Net cash flow provided by operating activities	181,444	235,682	223,738
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(96,924)	(127,302)	(244,151)
Disposals of property, plant and equipment	924	4,373	2,622
Proceeds from Divestiture of Businesses	1,001		23,950
Other	60	(47)	(757)
Net cash flow used for investing activities	(94,939)	(122,976)	(218,336)
FINANCING ACTIVITIES
Net (decrease) increase in notes payable	(6,067)	605	(175)
Net decrease in short-term revolving and other lines of credit	19,000	(500,000)	500,364
Term debt borrowings	0	297,867	0
Term debt repayments	0	(300,000)	0
Payment for Debt Extinguishment or Debt Prepayment Cost		(9,639)
Proceeds from Derivative Instrument, Financing Activities		10,198
Purchase of capital stock	(85,542)	(197)	(209)
The effect of employee benefit and stock plans and dividend reinvestment	(6,909)	821	(5,464)
Cash dividends paid to Shareholders	(66,565)	(66,735)	(66,303)
Other	(4,652)	(7,165)	(2,762)
Net cash flow (used for) provided by financing activities	(150,735)	(574,245)	425,451
Effect of exchange rate changes on cash and cash equivalents	(4,231)	8,902	(6,184)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(68,461)	(452,637)	424,669
CASH AND CASH EQUIVALENTS
Cash and cash equivalents, beginning of year	154,047	606,684	182,015
Cash and cash equivalents, end of year		154,047	606,684
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 85,586	$ 154,047	$ 606,684